Teresa Jackowska, MD

Center of Postgraduate Medical Education & Bielanski Hospital
Warsaw, Mazowieckie, Poland

Disclosure(s): MSD Poland, Merck & Co., Inc, Rahway, NJ, USA: Advisor/Consultant, Grant/Research Support, Honoraria, MSD - PI for this study

Presentation(s):

• 166 - A Phase 2b/3 Study to Evaluate the Efficacy and Safety of an Investigational Respiratory Syncytial Virus (RSV) Antibody, Clesrovimab, in Healthy Preterm and Full-Term Infants

  Thursday, October 17, 2024
  2:09 PM – 2:21 PM US PT